← Open Payments lookup

MONIQUE ALLMAN: Open Payments

NPI 1659605723 · KATY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,034 in 38 payments from 14 companies in 2025. Trend: 2023 $5,001 · 2024 $1,968 · 2025 $2,034

Food & beverage: $1,981Education: $53
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP11$688
GlaxoSmithKline, LLC.6$185
ARS Pharmaceuticals Operations, Inc.5$173
GENZYME CORPORATION2$168
Takeda Pharmaceuticals U.S.A., Inc.3$162
Incyte Corporation1$142
Eisai Inc.1$124
Galderma Laboratories, L.P.1$116
Bayer Healthcare Pharmaceuticals Inc.1$82
Pharming Healthcare, Inc.2$57

Products named: NEFFY, CUVITRU, NUCALA, WAYRILZ, Leqembi, NEMLUVIO, DUPIXENT, Kerendia.

Industry payments across TX — which companies pay providers there.